Bell Bank cut its position in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 13.0% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,055 shares of the company’s stock after selling 5,686 shares during the quarter. Bell Bank’s holdings in Kimberly-Clark were worth $5,414,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in KMB. William B. Walkup & Associates Inc. bought a new stake in Kimberly-Clark during the second quarter worth about $26,000. Crewe Advisors LLC bought a new position in Kimberly-Clark during the 1st quarter valued at approximately $27,000. New Millennium Group LLC bought a new stake in Kimberly-Clark in the second quarter worth $28,000. Strategic Financial Concepts LLC purchased a new stake in shares of Kimberly-Clark in the second quarter worth $32,000. Finally, DiNuzzo Private Wealth Inc. increased its holdings in shares of Kimberly-Clark by 808.0% during the third quarter. DiNuzzo Private Wealth Inc. now owns 227 shares of the company’s stock valued at $32,000 after acquiring an additional 202 shares in the last quarter. 76.29% of the stock is owned by hedge funds and other institutional investors.
Kimberly-Clark Stock Up 0.0 %
KMB opened at $132.19 on Thursday. Kimberly-Clark Co. has a 1-year low of $117.67 and a 1-year high of $149.30. The firm’s 50 day simple moving average is $140.40 and its two-hundred day simple moving average is $139.23. The company has a current ratio of 0.83, a quick ratio of 0.55 and a debt-to-equity ratio of 4.77. The company has a market capitalization of $44.08 billion, a PE ratio of 17.15, a PEG ratio of 2.78 and a beta of 0.40.
Kimberly-Clark Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Friday, December 6th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.69%. Kimberly-Clark’s payout ratio is currently 63.29%.
Wall Street Analysts Forecast Growth
KMB has been the topic of several recent analyst reports. Argus upgraded shares of Kimberly-Clark to a “hold” rating in a research note on Friday, July 26th. Wells Fargo & Company reduced their price target on shares of Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 24th. JPMorgan Chase & Co. cut their target price on Kimberly-Clark from $142.00 to $140.00 and set an “underweight” rating on the stock in a research note on Wednesday, October 23rd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $165.00 price target on shares of Kimberly-Clark in a report on Wednesday, October 23rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Kimberly-Clark from $146.00 to $147.00 and gave the stock a “hold” rating in a report on Tuesday, October 8th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $149.93.
Get Our Latest Stock Report on Kimberly-Clark
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Recommended Stories
- Five stocks we like better than Kimberly-Clark
- How to Invest in Insurance Companies: A GuideĀ
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
- Health Care Stocks Explained: Why You Might Want to Invest
- Unusual Trading Volume in Gerdau: A Signal for Buyers?
- What Are Trending Stocks? Trending Stocks Explained
- 3 Stocks Gaining Traction in Their Turnaround Stories
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.